Staphylococcal complement evasion by various convertase-blocking molecules.

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Bacteria must evade the host immune system, particularly the complement system, for successful infection.
• Staphylococcus aureus employs various strategies to counteract complement-mediated immunity.

Purpose of the Study:

• To identify and characterize novel complement inhibitors from Staphylococcus aureus.
• To elucidate the mechanism of action of these inhibitors against complement convertases.
• To evaluate their therapeutic potential for complement-mediated inflammatory diseases.

Main Methods:

• Identification of complement inhibitors in S. aureus.
• Biochemical assays to determine inhibition of C3 and C5 convertases.
• In vitro assays measuring C5a generation and neutrophil activation.
• In vivo mouse model of immune complex peritonitis to assess neutrophil recruitment.

Main Results:

• Four potent complement inhibitors were identified in S. aureus, belonging to a new immune evasion cluster.
• Two inhibitors are SCIN homologues, while Extracellular fibrinogen-binding protein (Efb) and Extracellular complement-binding protein (Ecb) block C3 and C5 convertases.
• Efb and Ecb effectively inhibit C5a generation and C5a-mediated neutrophil activation in vitro and Ecb reduces neutrophil recruitment in vivo.

Conclusions:

• Staphylococcus aureus utilizes novel proteins, Efb and Ecb, to effectively evade the complement system by inhibiting key convertases.
• These S. aureus-derived convertase inhibitors exhibit significant anti-inflammatory properties.
• Efb and Ecb represent promising therapeutic candidates for treating complement-mediated inflammatory conditions.